Fernando Martínez

Fernando Martínez

Auto-generated profile, based on publicly available information

Fernando Martínez

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2013 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
GLGuillermo Luxán
Guillermo Luxán
JCJesús C Casanova
Jesús C Casanova
BMBeatriz Martínez-Poveda
Beatriz Martínez-Poveda
BPBelén Prados
Belén Prados
GDGaetano D'Amato
Gaetano D'Amato
José Luis De La PompaJosé Luis De La Pompa
José Luis De La Pompa

7 December 2015 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
GDGaetano D’aMato
Gaetano D’aMato
GLGuillermo Luxán
Guillermo Luxán
GMGonzalo del Monte-Nieto
Gonzalo del Monte-Nieto
BMBeatriz Martínez-Poveda
Beatriz Martínez-Poveda
CTCarlos Torroja
Carlos Torroja
José Luis De La PompaJosé Luis De La Pompa
José Luis De La Pompa
Ventricular chambers are essential for the rhythmic contraction and relaxation occurring in every heartbeat throughout life. Congenital abnormalities in ventricular chamber formation cause severe human heart defects. How the early trabecular meshwork of myocardial fibres forms and subsequently develops into mature chambers is poorly understood. We show that Notch signalling first connects chamber endocardium and myocardium to sustain trabeculation, and later coordinates ventricular patterning and compaction with coronary vessel development to generate the mature chamber, through a temporal sequence of ligand signalling determined by the glycosyltransferase manic fringe (MFng). Early endocardial expression of MFng promotes Dll4–Notch1 signalling, which induces trabeculation in the developing ventricle. Ventricular maturation and compaction require MFng and Dll4 downregulation in the endocardium, which allows myocardial Jag1 and Jag2 signalling to Notch1 in this tissue. Perturbation of this signalling equilibrium severely disrupts heart chamber formation. Our results open a new research avenue into the pathogenesis of cardiomyopathies.

1 November 2012 in Cell Stem Cell
Verified
Journal Article
Closed access
IHIsabel Hidalgo
Isabel Hidalgo
AHAntonio Herrera-Merchan
Antonio Herrera-Merchan
JLJose Manuel Ligos
Jose Manuel Ligos
LCLaura Carramolino
Laura Carramolino
JNJavier Nuñez
Javier Nuñez
SGSusana Gonzalez
Susana Gonzalez

1 October 2019 in Circulation
Verified
Journal Article
Open access
PDF file
LPLaura Padrón-Barthe
Laura Padrón-Barthe
MVMaría Villalba-Orero
María Villalba-Orero
JGJesús M. Gómez-Salinero
Jesús M. Gómez-Salinero
FDFernando Domínguez
Fernando Domínguez
MRMarta Román
Marta Román
ELEnrique Lara-Pezzi
Enrique Lara-Pezzi
Background: Arrhythmogenic cardiomyopathy/arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiac disease characterized by fibrofatty replacement of the myocardium, resulting in heart failure and sudden cardiac death. The most aggressive arrhythmogenic cardiomyopathy/ARVC subtype is ARVC type 5 (ARVC5), caused by a p.S358L mutation in TMEM43 (transmembrane protein 43). The function and localization of TMEM43 are unknown, as is the mechanism by which the p.S358L mutation causes the disease. Here, we report the characterization of the first transgenic mouse model of ARVC5. Methods: We generated transgenic mice overexpressing TMEM43 in either its wild-type or p.S358L mutant (TMEM43-S358L) form in postnatal cardiomyocytes under the control of the α-myosin heavy chain promoter. Results: We found that mice expressing TMEM43-S358L recapitulate the human disease and die at a young age. Mutant TMEM43 causes cardiomyocyte death and severe fibrofatty replacement. We also demonstrate that TMEM43 localizes at the nuclear membrane and interacts with emerin and β-actin. TMEM43-S358L shows partial delocalization to the cytoplasm, reduced interaction with emerin and β-actin, and activation of glycogen synthase kinase-3β (GSK3β). Furthermore, we show that targeting cardiac fibrosis has no beneficial effect, whereas overexpression of the calcineurin splice variant calcineurin Aβ1 results in GSK3β inhibition and improved cardiac function and survival. Similarly, treatment of TMEM43 mutant mice with a GSK3β inhibitor improves cardiac function. Finally, human induced pluripotent stem cells bearing the p.S358L mutation also showed contractile dysfunction that was partially restored after GSK3β inhibition. Conclusions: Our data provide evidence that TMEM43-S358L leads to sustained cardiomyocyte death and fibrofatty replacement. Overexpression of calcineurin Aβ1 in TMEM43 mutant mice or chemical GSK3β inhibition improves cardiac function and increases mice life span. Our results pave the way toward new therapeutic approaches for ARVC5.

24 May 2023 in Nature
Verified
Journal Article
Closed access
PDF file
APAna Paredes
Ana Paredes
RJRaquel Justo
Raquel Justo
DJDaniel Jiménez-Blasco
Daniel Jiménez-Blasco
VNVanessa Núñez
Vanessa Núñez
ICIrene Calero
Irene Calero
MRMercedes Ricote
Mercedes Ricote

21 December 2022 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
FLFidel-Nicolás Lolo
Fidel-Nicolás Lolo
NWNikhil Walani
Nikhil Walani
ESEric Seemann
Eric Seemann
DZDobryna Zalvidea
Dobryna Zalvidea
DPDácil María Pavón
Dácil María Pavón
MPMiguel A. del Pozo
Miguel A. del Pozo
In response to different types and intensities of mechanical force, cells modulate their physical properties and adapt their plasma membrane (PM). Caveolae are PM nano-invaginations that contribute to mechanoadaptation, buffering tension changes. However, whether core caveolar proteins contribute to PM tension accommodation independently from the caveolar assembly is unknown. Here we provide experimental and computational evidence supporting that caveolin-1 confers deformability and mechanoprotection independently from caveolae, through modulation of PM curvature. Freeze-fracture electron microscopy reveals that caveolin-1 stabilizes non-caveolar invaginations—dolines—capable of responding to low-medium mechanical forces, impacting downstream mechanotransduction and conferring mechanoprotection to cells devoid of caveolae. Upon cavin-1/PTRF binding, doline size is restricted and membrane buffering is limited to relatively high forces, capable of flattening caveolae. Thus, caveolae and dolines constitute two distinct albeit complementary components of a buffering system that allows cells to adapt efficiently to a broad range of mechanical stimuli.